The financial calamities predicted at the beginning of the coronavirus pandemic didn't materialize for most healthcare startups.

The industry's up-and-coming private companies largely benefited from the one-two punch of financial concerns in other parts of the market and an increased focus on healthcare with all eyes on America's wavering pandemic response.

2020 will likely go down as one of the single most pivotal years for the US healthcare industry in history. Even outside large hospitals and pharmaceutical companies, private startups raised a whopping $17 billion in 2020, a 57% increase over 2019's record, according to a new report from Silicon Valley Bank.

That led to a new herd of healthcare unicorns, private companies valued at or above $1 billion. Some former unicorns, like GoodRx and Amwell, made public market debuts while others continued raising venture capital and private financings while the market was favorable. Some startups raised two separate funding rounds in the last year alone.

Read more: The 8 digital health startups to watch that are changing healthcare in 2021

Business Insider rounded up the 26 healthcare companies currently valued at more than $1 billion, according to Pitchbook and additional reporting.

More here:
The 26 billion-dollar startups to watch that are revolutionizing healthcare in 2021 - Business Insider